Displaying items by tag: Department of Medicine
The UA System Board of Trustees approved the creation of a new professorship and the appointment to fill it during its meeting June 17. Ashita Tolwani, M.D., was appointed the inaugural holder of the newly created DCI Edwin A. Rutsky, M.D., Distinguished Endowed Professorship in Nephrology.
.Eric Wallace is piloting telehealth program, which he says could open the door for Alabamians in rural communities to receive more subspecialized care without traveling long.
A workshop is set to provide information and resources for MDS patients and families June 25.
Tagged under
A UAB study in the Journal of the American Medical Association shows patients’ mobility while hospitalized helps maintain daily activity in older adults.
Tagged under
UAB’s Lung Health Center has joined the prestigious Airways Clinical Research Network established by the American Lung Association.
Tagged under
David Resuehr, Ph.D. and Ashita Tolwani, M.D., were two of 11 faculty members recognized across UAB as winners of the 2016 President’s Awards for Excellence in Teaching.
Tagged under
Two members of the School of Medicine faculty have been selected as fellows for the Hedwig van Ameringen Executive Leadership in Academic Medicine® for 2016-2017.
Tagged under
Eleven outstanding faculty members were named recipients of the 2016 Dean’s Excellence Awards, an honor recognizing exceptional contributions made by School of Medicine faculty in service, teaching, research, diversity enhancement and mentorship.
Tagged under
- school of medicine
- division of general internal medicine
- division of nephrology
- division of pulmonary, allergy and critical care medicine
- department of microbiology
- department of genetics
- division of infectious diseases
- department of medicine
- department of surgery
- department of pediatrics
- department of emergency medicine
UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
Tagged under
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Tagged under